Genistein Has Antiviral Activity against Herpes B Virus and Acts Synergistically with Antiviral Treatments to Reduce Effective Dose
Herpes B virus is a deadly zoonotic agent that can be transmitted to humans from the macaque monkey, an animal widely used in biomedical research. Currently, there is no cure for human B virus infection and treatments require a life-long daily regimen of antivirals, namely acyclovir and ganciclovir....
Main Authors: | Julia C. LeCher, Nga Diep, Peter W. Krug, Julia K. Hilliard |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-05-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/11/6/499 |
Similar Items
-
Analysis of antiviral drug properties of thymidine kinase of herpes B virus using recombinant herpes simplex virus 1
by: Phu Hoang Anh Nguyen, et al.
Published: (2024-01-01) -
Antiviral Drugs for EBV
by: Joseph S. Pagano, et al.
Published: (2018-06-01) -
Systematic reviews of ganciclovir versus acyclovir for herpes simplex virus keratitis
by: Jing-Yuan Li, et al.
Published: (2014-09-01) -
Current and Emerging Therapies for Ocular Herpes Simplex Virus Type-1 Infections
by: Raghuram Koganti, et al.
Published: (2019-10-01) -
Decision Tool for Herpes B Virus Antiviral Prophylaxis after Macaque-Related Injuries in Research Laboratory Workers
by: Sapha Barkati, et al.
Published: (2019-09-01)